Attached files
| file | filename |
|---|---|
| 10-Q - FORM 10-Q - Fibrocell Science, Inc. | c92967e10vq.htm |
| EX-10.1 - EXHIBIT 10.1 - Fibrocell Science, Inc. | c92967exv10w1.htm |
| EX-4.2 - EXHIBIT 4.2 - Fibrocell Science, Inc. | c92967exv4w2.htm |
| EX-4.1 - EXHIBIT 4.1 - Fibrocell Science, Inc. | c92967exv4w1.htm |
| EX-10.3 - EXHIBIT 10.3 - Fibrocell Science, Inc. | c92967exv10w3.htm |
| EX-31.1 - EXHIBIT 31.1 - Fibrocell Science, Inc. | c92967exv31w1.htm |
| EX-10.2 - EXHIBIT 10.2 - Fibrocell Science, Inc. | c92967exv10w2.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q for the fiscal quarter ended September 30,
2009 of Fibrocell Science, Inc. (the “Company”) as filed with the Securities and Exchange
Commission on the date hereof (the “Report”), I, Declan Daly, Chief Executive Officer of the
Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of
the Sarbanes-Oxley Act of 2002, that:
| • | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C 78m or 78o(d)); and |
| • | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| Date: November 23, 2009 | By: | /s/ Declan Daly | ||
| Declan Daly | ||||
| (Principal Executive Officer and Principle Financial Officer) | ||||
A signed original of this written statement required by Section 906 has been provided to Fibrocell
Science, Inc. and will be retained by Fibrocell Science, Inc. and furnished to the Securities and
Exchange Commission or its staff upon request.